Holmdel, NJ, United States of America

Ying-Duo Gao

USPTO Granted Patents = 26 

 

Average Co-Inventor Count = 9.2

ph-index = 4

Forward Citations = 65(Granted Patents)


Location History:

  • Neshanic Station, NJ (US) (2000)
  • Meshanie Station, NJ (US) (2003 - 2008)
  • Edison, NJ (US) (2001 - 2012)
  • Holmdel, NJ (US) (2016 - 2019)

Company Filing History:


Years Active: 2000-2025

Loading Chart...
Loading Chart...
26 patents (USPTO):

Title: A Spotlight on Ying-Duo Gao: Innovator in Pharmaceutical Sciences

Introduction

Ying-Duo Gao, an accomplished inventor based in Holmdel, NJ, is known for his significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 24 patents, he has made remarkable advancements in the development of therapeutic compounds, particularly in the area of coagulation research.

Latest Patents

Among his latest inventions are notable patents focusing on Factor XIA inhibitors. These patents describe a compound of Formula (I) and pharmaceutical compositions that encompass one or more of these compounds. They detail methods for using these compounds to treat or prevent thromboses, embolisms, hypercoagulability, or fibrotic changes. Moreover, these compounds are identified as selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma Kallikrein, paving the way for potentially transformative treatments for patients facing serious clotting disorders.

Career Highlights

Throughout his career, Ying-Duo Gao has worked with renowned companies, particularly Merck Sharp & Dohme Corporation. His tenure at Merck demonstrates his commitment to advancing pharmaceutical research and innovation. His extensive experience has not only contributed to his personal achievements but has also played a crucial role in the development of therapies that benefit the medical community and patients alike.

Collaborations

Collaboration plays a significant role in Gao's career, as he has had the opportunity to work alongside esteemed colleagues such as Carlo Brugnara and Jose Alberto Halperin. These partnerships have likely catalyzed innovation and fostered a collaborative environment conducive to groundbreaking discoveries in pharmaceuticals.

Conclusion

In summary, Ying-Duo Gao's contributions to the field of pharmaceutical sciences are commendable. With a focus on Factor XIA inhibitors and a history of collaboration with key figures in the industry, he continues to impact the way medical professionals approach coagulation disorders. As his work progresses, the innovations stemming from his patents hold the promise of enhancing patient care and treatment outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…